Regulation of the vaginal microbiome reduces rate of HIV infection
- 總結
- This technology is a combination of vaccines, probiotics, and antibiotics that regulate the vaginal microbiome to reduce the infection rate of human immunodeficiency virus (HIV) and other sexually transmitted infections (STIs).
- 技術優勢
- Cost-effective prevention of HIV infectionAlso reduces risk of infection with other STIs
- 技術應用
- Preventative vaccine to reduce HIV infection risk Antibiotics for prevention of HIV and STIsVaginal probiotics to maintain a healthy bacterial microbiome
- 詳細技術說明
- None
- *Abstract
-
None
- *Inquiry
- Ron KatzColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu
- *IR
- CU17009
- *Principal Investigation
-
- *Publications
- Masson L, Passmore JA, Liebenberg LJ, Werner L, Baxter C, Arnold KB, Williamson C, Little F, Mansoor LE, Naranbhai V, Lauffenburger DA, Ronacher K, Walzl G, Garrett NJ, Williams BL, Couto-Rodriguez M, Hornig M, Lipkin WI, Grobler A, Abdool Karim Q, Abdool Karim SS. “Genital inflammation and the risk of HIV acquisition in women.” Clin Infect Dis. 2015 Jul 15;61(2):260-9.Tech Ventures Reference:IR CU17009Licensing Contact: Ron Katz
- 國家/地區
- 美國
欲了解更多信息,請點擊 這裡
